SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-057871
Filing Date
2012-08-14
Accepted
2012-08-14 17:08:52
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-13951_110q.htm 10-Q 807270
2 EX-31.1 a12-13951_1ex31d1.htm EX-31.1 9940
3 EX-31.2 a12-13951_1ex31d2.htm EX-31.2 9982
4 EX-32.1 a12-13951_1ex32d1.htm EX-32.1 7748
  Complete submission text file 0001104659-12-057871.txt   2959438

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hlcs-20120630.xml EX-101.INS 226092
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hlcs-20120630.xsd EX-101.SCH 32365
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hlcs-20120630_cal.xml EX-101.CAL 80481
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT hlcs-20120630_lab.xml EX-101.LAB 438856
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hlcs-20120630_pre.xml EX-101.PRE 176639
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hlcs-20120630_def.xml EX-101.DEF 127440
Mailing Address ONE KENDALL SQUARE BUILDING 200 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200 CAMBRIDGE MA 02139 617-649-0540
HELICOS BIOSCIENCES CORP (Filer) CIK: 0001274563 (see all company filings)

IRS No.: 050587367 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33484 | Film No.: 121034174
SIC: 2834 Pharmaceutical Preparations